Rhenman & Partners Asset Management AB - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 159 filers reported holding IMMUNOMEDICS INC in Q3 2017. The put-call ratio across all filers is 0.59 and the average weighting 0.5%.

Quarter-by-quarter ownership
Rhenman & Partners Asset Management AB ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$18,821,000
+15.5%
221,351
-51.9%
1.67%
-5.0%
Q2 2020$16,302,000
+105.0%
460,000
-22.0%
1.76%
+58.1%
Q1 2020$7,953,000
-46.3%
590,000
-15.7%
1.11%
-31.4%
Q4 2019$14,812,000
+31.4%
700,000
-17.6%
1.62%
+14.9%
Q3 2019$11,271,000
-4.5%
850,000
-0.2%
1.41%
+8.6%
Q2 2019$11,808,000
-0.3%
851,367
+38.1%
1.30%
-6.1%
Q1 2019$11,840,000
+72.7%
616,367
+28.3%
1.38%
+76.9%
Q4 2018$6,854,000
-22.6%
480,330
+12.9%
0.78%
-11.8%
Q3 2018$8,860,000
-17.8%
425,330
-6.6%
0.89%
-19.5%
Q2 2018$10,778,000
+77.6%
455,330
+9.6%
1.10%
+47.5%
Q1 2018$6,068,000
-21.8%
415,330
-13.5%
0.75%
-28.7%
Q4 2017$7,762,000
+11.0%
480,330
-3.9%
1.05%
+17.6%
Q3 2017$6,990,000
+49.5%
500,000
-5.6%
0.89%
+32.9%
Q2 2017$4,676,000
+50.7%
529,610
+10.4%
0.67%
+36.7%
Q1 2017$3,103,000479,6100.49%
Other shareholders

There were no reported owners of IMMUNOMEDICS INC in Q3 2017.

NameSharesValueWeighting ↓
View complete list of IMMUNOMEDICS INC shareholders